University of Florida Research Foundation and Diamyd Medical settle lawsuit

University of Florida Research Foundation and Diamyd Medical settle
lawsuit

University of Florida Research Foundation, Incorporated (“UFRF”), and
Diamyd Medical AB today jointly announced that they have settled the
breach of contract litigation that UFRF filed in the United States
Federal District Court in Florida against Diamyd Medical in January
2011.

The dispute related to an exclusive license agreement between UFRF and
Diamyd Medical, and to a sublicense of the rights under the exclusive
license agreement between Diamyd Medical and Ortho-McNeil-Janssen
Pharmaceuticals, Inc., which sublicense involved rights to the
GAD65-based drug candidate Diamyd®.

UFRF and Diamyd Medical have amicably settled their dispute for an
undisclosed settlement amount. The settlement amount is in line with
what Diamyd Medical has reserved in its accounts as per August 31, 2011
regarding litigation claims. UFRF and Diamyd Medical declined further
comment on the matter, citing the confidentiality of their settlement.

For more information, please contact:
Peter Zerhouni, President and CEO Diamyd Medical AB (publ.)
Phone: +46 8 661 0026

For press material, please contact:
Andreas Ericsson, Diamyd Medical AB (publ.)
press@diamyd.com
Phone: +46 8 661 0026